Results
The survey tested the suggestion that biodefense researchers simply do not want select agents regulated, and it was disproved by a wide margin: 93.4% responded that select agents should be regulated.
Biodefense researchers surveyed indicated that the Biosafety in Microbiological and Biomedical Laboratories (BMBL) guidance was not as widely accepted as has been suggested, with 41% of respondents preferring clear regulatory guidance over the BMBL.
1 Instead of less regulation, respondents indicated that more specificity is needed for training requirements in BSL (88.4%), regulatory compliance (76.3%), and emergency response (61.1%) training, rather than merely what is ''appropriate.'' 2 One of the most controversial components, the inventory requirement, scored low, with 24.5% responding that the inventory approach is not useful at all. 3 A biosecurity background investigation of biodefense researchers 4 received higher marks, with 16.7% ranking this as the most effective component (among 10) of the regulation.
Given the concern about uncertainty in the regulation, and several high-profile civil and criminal matters, several ''anxiety factor'' questions were asked: ''How concerned are you about inadvertently violating the select agent regulations, which would have negative repercussions on your career?,'' with 1 being the least concerned and 5 being the most concerned. The findings indicate a relatively high level of concern: 64% selected values of 3-5, on the high end of the continuum. For perspective, a comparative concern question was asked, with the same scale: ''How concerned are you about injury or death in your work?'' Many of the researchers surveyed work with the deadliest pathogens on earth, but a different response emerged: 84% selected values of 1-3, the low end of the continuum. While not a perfect mirror image (Figure 1) , the suggestion of an inversely proportional relationship between these concerns presents a troubling public policy picture: the doubtful desirability of a regulatory program that provokes this very high level of anxiety among biodefense researchers over fear of inadvertently violating the regulations.
When respondents were asked whether they would use a hotline for legal compliance questions, guaranteeing anonymity, 59% responded affirmatively, further supporting
the finding of significant concern for inadvertently violating the regulations. 5 
Conclusion
These findings indicate that the Select Agent Program, after its first 5 years, has flaws that may thwart it from achieving its statutory goals. Among the flaws is a measure of ''anxiety'' among those in the regulated community that suggests that the program should be reviewed, with an eye toward making it more effective and less anxiety provoking. 
